Australia's largest stock trading and investment forum Australia's #1 stock forum

AN1

Click for more information

0.00%

0.8¢ anagenics limited

What percentage of Infectious mono patients would you expect to...

First 314 Last

Share
Profile

Follow
Ooogerbooger

1,612 Posts.

409

04/04/20

20:50

Post #: 43882018
Share

Originally posted by uktion: ↑

Rapid antigen test certainly has a role to play in detection of positive patients after the pandemic is contained and probably after the vaccine is out. However what we don't know is that if you have antibodies against sars-cov-2, does it stop you from getting infected again? If it is yes (lots of studies currently suggest otherwise), it will have some use but if the answer is no, what is the point? It's something we will find out in the near future.

Side note:
I want to make sure to those people who think rapid antigen tests are useless, that's certainly not true.In day to day laboratory settings in Australia, most common rapid antigen tests include detection of malaria and infectious mononucleosis.
They are usually run in conjunction with other methods to confirm the test results but if it is positive we can be sure that it is true positive. So the clinician can treat patients accordingly.

Expand

What percentage of Infectious mono patients would you expect to return positive results to a rapid antigen test at day 7-10 of infection?

CDY Price at posting: 27.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

There are more pages in this discussion • 150 more messages in this thread...

First 314 Last

Add AN1 (ASX) to my watchlist